EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The GAIP-interacting protein C-terminal 1 (GIPC1) in health and disease: An update

Yifang Li, Jian Jiao

Ageing Research Reviews · 2026-11 · 122 · 103363

DOI: 10.1016/j.arr.2026.103363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-11. Verfasst von Yifang Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology & Hepatology, China-Japan Union Hospital, Jilin University, Changchun, 130033, China. Electronic address: yifang22@mai…. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Neoplasms. Die Arbeit nennt 174 Literaturangaben. Gefördert von: Department of Finance of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GAIP-interacting protein C-terminal 1 (GIPC1/GIPC) is a well-established protein in the field of cancer biology. Recent studies have revealed that GIPC1 may exert opposing, context-dependent functions in various diseases or physiological processes, although the underlying regulatory mechanisms remain to be explored. Since GIPC1 contains a PDZ domain that interacts with various proteins, this domain is a promising therapeutic target. Molecular probes designed against the GIPC1-PDZ domain could therefore be valuable in developing targeted interventions. This review systematically summarizes the advances in GIPC1 research over the past decade. We discuss recent progress in understanding the roles of GIPC1 and its interacting proteins in human pathophysiology and disease, with a focus on GIPC1-interacting molecules and associated signaling pathways. Additionally, we identify key obstacles that must be overcome to realize the therapeutic potential of GIPC1. This review proposes an emerging conceptual model in which GIPC1 functions primarily as a context-dependent "signal tuner" and "trafficking gatekeeper," rather than as a simple scaffolding protein. This paradigm shift fundamentally transforms our understanding of how GIPC1 integrates diverse receptor inputs to regulate cellular behavior and highlights new directions for targeted therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingNeoplasmsHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

AgeingCancerGIPC1PDZ structural domain

Substanzen

Adaptor Proteins, Signal TransducingGIPC1 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology & Hepatology, China-Japan Union Hospital, Jilin University, Changchun, 130033, China. Electronic address: yifang22@mails.jlu.edu.cn.
  • Department of Gastroenterology & Hepatology, China-Japan Union Hospital, Jilin University, Changchun, 130033, China. Electronic address: jjian@jlu.edu.cn.

Förderung

  • Department of Finance of Jilin Province

Zitieren

APA

Li, Y., & Jiao, J. (2026). The GAIP-interacting protein C-terminal 1 (GIPC1) in health and disease: An update. Ageing Research Reviews, 122, 103363. https://doi.org/10.1016/j.arr.2026.103363

Vancouver

Li Y, Jiao J. The GAIP-interacting protein C-terminal 1 (GIPC1) in health and disease: An update. Ageing Research Reviews. 2026;122:103363. doi:10.1016/j.arr.2026.103363

BibTeX
@article{Li2026,
  author = {Li, Yifang and Jiao, Jian},
  title = {The GAIP-interacting protein C-terminal 1 (GIPC1) in health and disease: An update},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {122},
  pages = {103363},
  doi = {10.1016/j.arr.2026.103363}
}
Kostenlos starten →